Table 2.
Characteristics of subjects at baseline in each experimental group
| Characteristics | IS | IFS | MMS | FW | FCF |
|---|---|---|---|---|---|
| N | 40 | 42 | 36 | 48 | 51 |
| Age (m) | 20.3 ± 9.4 | 20.8 ± 8.9 | 23.6 ± 9.1 | 22.4 ± 9.5 | 21.8 ± 8.9 |
| Boys | 42.5 | 47.6 | 47.2 | 52.1 | 52.9 |
| Ferritin < 7 μg/L | 50 | 31.6 | 56.3 | 30.4 | 44.9 |
| Iron < 50 μg/dL | 14.3 | 11.4 | 3.3 | 6.7 | 16.7 |
| Height for age < -2SD | 32.5 | 19 | 20 | 27.1 | 17.6 |
| Weight for height < -2SD | 2.5 | 7.1 | 0 | 4.2 | 0 |
| Weight for age < -2SD | 2.5 | 0 | 0 | 0 | 0 |
Values are % or mean ± SD. There were no significant differences among treatments with Chi square or ANOVA.
Treatment abbreviations: Iron supplement (IS), iron plus folic acid supplement (IFS), multiple micronutrients supplement (MMS), micronutrient fortified complementary food as porridge powder (FCF), or zinc, iron and ascorbic acid fortified water (FW).
There are no significant differences among treatment groups with ANOVA or Chi Square tests.